Search
metformin/sitagliptin; januvia/metformin (Janumet)
Indications:
- treatment of diabetes mellitus type 2
Contraindications:
- renal failure: eGFR < 30 mL/min/1.73 m2
- metabolic acidosis
- not for use in treatment of diabetes mellitus type 1
Dosage:
- BID dosing
- 50 mg sitagliptin + 500 mg or 1000 mg metformin
Interactions
drug adverse effects of hypoglycemic agents
General
hypoglycemic combination
References
- Prescriber's Letter 14(5): 2007
Januvia's Place in Therapy
Detail-Document#: 230511
(subscription needed) http://www.prescribersletter.com
- Highlights of Prescribing Information
JanuMet (sitagliptin & metformin extended release) for oral use
https://www.merck.com/product/usa/pi_circulars/j/janumet/janumet_pi.pdf
- Highlights of Prescribing Information
JanuMet XR (sitagliptin & metformin hydrochloride) for oral use
https://www.merck.com/product/usa/pi_circulars/j/janumet_xr/janumet_xr_pi.pdf
Components
metformin (Glucophage)
sitagliptin (Januvia)